Shares of pharmaceutical companies Sanofi India and Cipla gained on Wednesday, March 27, after the firms announced an exclusive distribution tie-up for expanding the reach of Sanofi’s Central Nervous System (CNS) portfolio, including its six brands.
Sanofi India share price today
Sanofi India shares surged as much as 3.77 per cent to the day’s high of Rs 7,999 in early morning deals on the NSE. At 9:41 AM, the counter traded 2.35 per cent higher at Rs 7,889.25 on the NSE.
Cipla share price today
Cipla stock rose as much as 1.61 per cent to the day’s high of Rs 1,496 in early morning deals on NSE. At 9:40 AM, the counter traded 0.32 per cent higher at Rs 1,476.9 on the NSE.
According to a regulatory filing released post-market hours on Wednesday, Sanofi India Limited, Sanofi Healthcare India Private Limited, and Cipla Limited announced an exclusive distribution and marketing partnership for the sale and promotion of Sanofi India’s Central Nervous System (CNS) product line in India on March 26.
As part of this collaboration, Cipla will handle the distribution of Sanofi India’s six CNS brands, including the industry-leading Frisium® brand of anti-epileptic drugs.
According to the joint statement, Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, and Cipla will leverage its capabilities and network of marketing and sales professionals, distributors, institutions, and market outreach programmes to expand access to these treatments for patients who need them.
